AU Stock MarketDetailed Quotes
ACW Actinogen Medical Ltd
- 0.023
- 0.0000.00%
20min DelayMarket Closed Nov 8 16:00 AET
70.90MMarket Cap-3833P/E (Static)
0.024High0.023Low1.88MVolume0.023Open0.023Pre Close44.11KTurnover0.09952wk High0.09%Turnover Ratio3.08BShares0.01952wk Low-0.006EPS TTM50.26MFloat Cap1.777Historical HighLossP/E (Static)2.19BShs Float0.007Historical Low-0.006EPS LYR4.35%Amplitude--Dividend TTM3.83P/B1Lot Size--Div YieldTTM
About Actinogen Medical Ltd Company
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.
Company Profile
SymbolACW
Company NameActinogen Medical Ltd
Founded1999
MarketASX
Fiscal Year Ends06-30
Address109 Pitt Street Level 9, Suite 901
CitySydney
CountryAustralia
Zip Code2000
Phone+61 289647401
Websitehttps://www.actinogen.com.au
Share RegistryAUTOMIC REGISTRY SERVICES
Level 1, 45 Clarence Street, SYDNEY, NSW, AUSTRALIA, 2000
13 25 83
Company Executives
- Name
- Position
- Salary
- Steven Gourlay
- Executive Director, Chief Executive Officer and Managing Director
- --
- Jeff Carter
- Chief Financial Officer
- --
- Dana Hilt
- Chief Medical Officer
- --
- Tamara Miller
- Senior Vice President - Product Development
- --
- Geoffrey E.D Brooke
- Non-Executive Chairman of the Board
- --
- Nicki Vasquez
- Non-Executive Director
- --
- Malcolm John McComas
- Non-Executive Director
- --
- George Morstyn
- Non-Executive Director
- --
- Peter Webse
- Company Secretary
- --
- Michael Roberts
- Investor Relations
- --
- Fujun Li
- Head of Manufacturing
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data